|
1
|
Jemal A and Bray F; Center MM300. Ferlay
J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee N, Harris J, Garden AS, et al:
Intensity-modulated radiation therapy with or without chemotherapy
for nasopharyngeal carcinoma: radiation therapy oncology group
phase II trial 0225. J Clin Oncol. 27:3684–3690. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen YP, Wang ZX, Chen L, et al: A
Bayesian network meta-analysis comparing concurrent
chemoradiotherapy followed by adjuvant chemotherapy, concurrent
chemoradiotherapy alone and radiotherapy alone in patients with
locoregionally advanced nasopharyngeal carcinoma. Ann Oncol. Oct
29–2014.(Epub ahead of print). PubMed/NCBI
|
|
4
|
Fang FM, Tsai WL, Chien CY, et al:
Pretreatment quality of life as a predictor of distant metastasis
and survival for patients with nasopharyngeal carcinoma. J Clin
Oncol. 28:4384–4389. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
OuYang PY, Xie C, Mao YP, et al:
Significant efficacies of neoadjuvant and adjuvant chemotherapy for
nasopharyngeal carcinoma by meta-analysis of published
literature-based randomized, controlled trials. Ann Oncol.
24:2136–2146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu LY, Pan J, Wu JX, et al: Factors
associated with overall survival in 1706 patients with
nasopharyngeal carcinoma: significance of intensive neoadjuvant
chemotherapy and radiation break. Radiother Oncol. 96:94–99. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Buergy D, Wenz F, Groden C and Brockmann
MA: Tumor-platelet interaction in solid tumors. Int J Cancer.
130:2747–2760. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu CC, Chang KW, Chou FC, et al:
Association of pretreatment thrombocytosis with disease progression
and survival in oral squamous cell carcinoma. Oral Oncol.
43:283–288. 2007. View Article : Google Scholar
|
|
9
|
Shimada H, Oohira G, Okazumi S, et al:
Thrombocytosis associated with poor prognosis in patients with
esophageal carcinoma. J Am Coll Surgeons. 198:737–741. 2004.
View Article : Google Scholar
|
|
10
|
Pedersen LM and Milman N: Prognostic
significance of thrombocytosis in patients with primary lung
cancer. Eur Respir J. 9:1826–1830. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hwang SG, Kim KM, Cheong JH, et al: Impact
of pretreatment thrombocytosis on blood-borne metastasis and
prognosis of gastric cancer. Eur J Surg Oncol. 38:562–567. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Taucher S, Salat A, Gnant M, et al:
Austrian Breast and Colorectal Cancer Study Group: Impact of
pretreatment thrombocytosis on survival in primary breast cancer.
Thromb Haemost. 89:1098–1106. 2003.PubMed/NCBI
|
|
13
|
Qiu MZ, Xu RH, Ruan DY, et al: Incidence
of anemia, leukocytosis, and thrombocytosis in patients with solid
tumors in China. Tumor Biol. 31:633–641. 2010. View Article : Google Scholar
|
|
14
|
Hassan BA, Yusoff ZB, Hassali MA and Bin
Othman S: Treatment patterns and outcomes in management of solid
cancer patients suffering from thrombocytopenia in Penang hospital.
Asian Pac J Cancer Prev. 12:2841–2845. 2011.PubMed/NCBI
|
|
15
|
Alidina A, Gaffar A, Hussain F, et al:
Survival data and prognostic factors seen in Pakistani patients
with esophageal cancer. Ann Oncol. 15:118–122. 2004. View Article : Google Scholar
|
|
16
|
Schwarz RE and Keny H: Preoperative
platelet count predicts survival after resection of periampullary
adenocarcinoma. Hepatogastroenterology. 48:1493–1498.
2001.PubMed/NCBI
|
|
17
|
Domínguez I, Crippa S, Thayer SP, et al:
Preoperative platelet count and survival prognosis in resected
pancreatic ductal adenocarcinoma. World J Surg. 32:1051–1056. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao J, Zhang HY and Xia YF: Increased
platelet count is an indicator of metastasis in patients with
nasopharyngeal carcinoma. Tumour Biol. 34:39–45. 2013. View Article : Google Scholar
|
|
19
|
Vadhan-Raj S: Management of
chemotherapy-induced thrombocytopenia: current status of
thrombopoietic agents. Semin Hematol. 46(Suppl 2): S26–S32. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pan J, Xu Y, Qiu S, et al: A comparison
between the Chinese 2008 and the 7th edition AJCC staging systems
for nasopharyngeal carcinoma. Am J Clin Oncol. Apr 19–2013.(Epub
ahead of print). View Article : Google Scholar
|
|
21
|
Brown KM, Domin C, Aranha GV, Yong S and
Shoup M: Increased preoperative platelet count is associated with
decreased survival after resection for adenocarcinorna of the
pancreas. Am J Surg. 189:278–282. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rodriguez GC, Clarke-Pearson DL, Soper JT,
et al: The negative prognostic implications of thrombocytosis in
women with stage IB cervical cancer. Obstet Gynecol. 83:445–448.
1994.PubMed/NCBI
|
|
23
|
Edge SB, Byrd DR, Compton CC, et al: AJCC
Cancer Staging Manual. 7th edition. Springer; New York, NY:
2010
|
|
24
|
Nash GF, Turner LF, Scully MF and Kakkar
AK: Platelets and cancer. Lancet Oncol. 3:425–430. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Levi M: Disseminated intravascular
coagulation in cancer patients. Best Pract Res Clin Haematol.
22:129–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schwarz RE: Platelet counts and prognosis
of pancreatic cancer. Lancet. 353:2158–2159. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kantarjian H, Giles F, List A, et al: The
incidence and impact of thrombocytopenia in myelodysplastic
syndromes. Cancer. 109:1705–1714. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Santolaya ME, Alvarez AM, Becker A, et al:
Prospective, multicenter evaluation of risk factors associated with
invasive bacterial infection in children with cancer, neutropenia,
and fever. J Clin Oncol. 19:3415–3421. 2001.PubMed/NCBI
|
|
29
|
Kaser A, Brandacher G, Steurer W, et al:
Interleukin-6 stimulates thrombopoiesis through thrombopoietin:
role in inflammatory thrombocytosis. Blood. 98:2720–2725. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Möhle R, Green D, Moore MA, Nachman RL and
Rafii S: Constitutive production and thrombin-induced release of
vascular endothelial growth factor by human megakaryocytes and
platelets. Proc Natl Acad Sci USA. 94:663–668. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Okamoto E, Osaki M, Kase S, Adachi H,
Kaibara N and Ito H: Thymidine phosphorylase expression causes both
the increase of intratumoral microvessels and decrease of apoptosis
in human esophageal carcinomas. Pathol Int. 51:158–164. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shimada H, Hoshino T, Okazumi S, et al:
Expression of angiogenic factors predicts response to
chemoradiotherapy and prognosis of oesophageal squamous cell
carcinoma. Br J Cancer. 86:552–557. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shimada H, Takeda A, Shiratori T, et al:
Prognostic significance of serum thymidine phosphorylase
concentration in esophageal squamous cell carcinoma. Cancer.
94:1947–1954. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pipili-Synetos E, Papadimitriou E and
Maragoudakis ME: Evidence that platelets promote tube formation by
endothelial cells on matrigel. Br J Pharmacol. 125:1252–1257. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
van Doormaal FF, Raskob GE, Davidson BL,
et al: Treatment of venous thromboembolism in patients with cancer:
Subgroup analysis of the Matisse clinical trials. Thromb Haemost.
101:762–769. 2009.PubMed/NCBI
|
|
36
|
Ahmed S, Shahid RK, Bhatt H, Lee-Ying R
and Lim J: Chemotherapy-related thrombocytosis: Does it increase
the risk of thromboembolism? Oncology. 82:327–332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zecchina G, Ghio P, Bosio S, et al:
Reactive thrombocytosis might contribute to chemotherapy-related
thrombophilia in patients with lung cancer. Clin Lung Cancer.
8:264–267. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schiffer CA, Anderson KC, Bennett CL, et
al: American Society of Clinical Oncology: Platelet transfusion for
patients with cancer: clinical practice guidelines of the American
Society of Clinical Oncology. J Clin Oncol. 19:1519–1538.
2001.PubMed/NCBI
|
|
39
|
Yang KY, Zhang T, Chen J, et al: Immune
thrombocytopenia as a paraneoplastic syndrome in patients with
nasopharyngeal cancer. Head Neck. 34:127–130. 2012. View Article : Google Scholar
|
|
40
|
Lei W, Liang J, Chen WG, et al:
Effectiveness and safety of recombinant human interleukin-11 in the
treatment of chemotherapy-induced thrombocytopenia. Zhonghua Zhong
Liu Za Zhi. 28:542–544. 2006.(In Chinese). PubMed/NCBI
|
|
41
|
Amirkhosravi A, Mousa SA, Amaya M, et al:
Inhibition of tumor cell-induced platelet aggregation and lung
metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost.
90:549–554. 2003.PubMed/NCBI
|
|
42
|
Amirkhosravi A, Mousa SA, Amaya M and
Francis JL: Antimetastatic effect of tinzaparin, a
low-molecular-weight heparin. J Thromb Haemost. 1:1972–1976. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kuderer NM, Khorana AA, Lyman GH and
Francis CW: A meta-analysis and systematic review of the efficacy
and safety of anticoagulants as cancer treatment-Impact on survival
and bleeding complications. Cancer. 110:1149–1161. 2007. View Article : Google Scholar : PubMed/NCBI
|
